ALZHEIMER DISEASE, EARLY ONSET
Clinical trials for ALZHEIMER DISEASE, EARLY ONSET explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER DISEASE, EARLY ONSET trials appear
Sign up with your email to follow new studies for ALZHEIMER DISEASE, EARLY ONSET, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could flickering lights and sounds slow Alzheimer's? new study aims to find out.
Disease control Recruiting nowThis study tests whether a special light and sound device used at home for 6 months can help people with mild Alzheimer's. The device uses a 40Hz frequency to boost brain waves, which in animal studies reduced harmful protein buildup and improved memory. Researchers will measure …
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Massachusetts Institute of Technology • Aim: Disease control
Last updated May 26, 2026 05:32 UTC
-
Brain zapping trial aims to halt Alzheimer's decline
Disease control Recruiting nowThis study tests whether a non-invasive brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS) can slow down cognitive decline in people with early Alzheimer's disease. Researchers will treat 55 participants with either real or sham rTMS over 24 we…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Willem de Haan • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for Alzheimer's? early trial tests DNL628
Disease control Recruiting nowThis early-stage study tests an experimental drug called DNL628 in people with early Alzheimer's disease. The main goal is to check if the drug is safe and how the body processes it. About 68 participants will receive either the drug or a placebo. This is a first step to see if D…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: PHASE1 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New Alzheimer's drug enters human trials: could it slow memory loss?
Disease control Recruiting nowThis study is testing an experimental drug called ARO-MAPT-SC in healthy volunteers and people with early Alzheimer's disease. The goal is to see if the drug is safe and how the body processes it. The drug works by targeting a protein linked to Alzheimer's, with the hope of slowi…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: PHASE1, PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Zapping the brain to fight forgetfulness and depression in early dementia
Symptom relief Recruiting nowThis study tests whether a gentle, non-invasive brain stimulation (tDCS) combined with cognitive training can improve thinking skills and mood in people with mild cognitive impairment or early dementia. Fifty participants will receive both real and placebo stimulation in two sepa…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: University of Campania Luigi Vanvitelli • Aim: Symptom relief
Last updated May 26, 2026 05:29 UTC
-
Drug vs. brain games: which works better for Alzheimer's?
Symptom relief Recruiting nowThis study compares two approaches for people newly diagnosed with early Alzheimer's: taking the drug donepezil versus doing non-drug cognitive activities. Researchers want to see which one better slows down memory and thinking decline over 6 months. About 240 adults aged 50 and …
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated May 26, 2026 05:29 UTC
-
Brain training and tai chi: new hope for early Alzheimer's?
Symptom relief Recruiting nowThis study looks at whether computerized brain exercises and Tai Chi/Qi Gong can improve memory, thinking, and mood in people with early-onset Alzheimer's disease. About 60 participants will be assigned to either the training program or an active control group. The goal is to see…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Indiana University • Aim: Symptom relief
Last updated May 20, 2026 11:54 UTC
-
New Alzheimer's drug takes first step in patients
Symptom relief Recruiting nowThis study tests a new drug called THN391 in 15 people with early Alzheimer's disease to see if it is safe and how the body handles it. Participants will receive three monthly doses of the drug or a placebo and undergo blood tests, brain scans, spinal taps, and memory tests. This…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: PHASE1 • Sponsor: Therini Bio, Inc. • Aim: Symptom relief
Last updated May 18, 2026 12:01 UTC
-
New brain scan method aims to spot Alzheimer's and Parkinson's early
Knowledge-focused Recruiting nowThis study is testing whether a new, low-cost brain scan can find early signs of Alzheimer's and Parkinson's disease. Researchers will compare brain scans from 120 people — including those at risk for Alzheimer's, those with Parkinson's, and healthy volunteers — to see if they ca…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 05:37 UTC
-
New MRI technique could spot Alzheimer's years before symptoms worsen
Knowledge-focused Recruiting nowThis study is testing a new, non-invasive MRI technique to find early brain changes linked to Alzheimer's disease. Researchers will scan the brains of 50 people with mild memory concerns and compare them to healthy volunteers. The goal is to develop a simple, affordable way to id…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC